Breaking News
A biotechnology company, INOVIO, says the first participant in Lassa vaccine trial has been dosed
A biotechnology company, INOVIO, says the first participant in Lassa vaccine trial has been dosed in a Phase 1B clinical trial for INO-4500, ...
Recent Comments